Home  >  Products  >  CACNB2 (calcium channel, voltage-dependent, beta 2 subunit) Blocking Peptide (the C terminal of CACNB2)(100ug)
CACNB2 (calcium channel, voltage-dependent, beta 2 subunit) Blocking Peptide (the C terminal of CACNB2)(100ug)

CACNB2 (calcium channel, voltage-dependent, beta 2 subunit) Blocking Peptide (the C terminal of CACNB2)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-CACNB2 Antibody (ARP34956_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP34956
Size: 100ug
Weight: 68kDa
Gene: 783
Format: Lyophilized powder
Target: CACNB2 belongs to the calcium channel beta subunit family.The beta subunit of voltage-dependent calcium channels contributes to the function of the calcium channel by increasing peak calcium current, shifting the voltage dependencies of activation and inactivation, modulating G protein inhibition and controlling the alpha-1 subunit membrane targeting.Defects in CACNB2 are the cause of Brugada syndrome type 4 (BRS4).
Alternative names: CACNLB2; CAVB2; FLJ23743; MYSB